Prestige Consumer Healthcare (PBH) Net Cash Flow Growth (3y) (2013 - 2025)
Prestige Consumer Healthcare (PBH) Net Cash Flow Growth (3y) (2013 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | NCF Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.77 Bn | 35.04 Bn | 1.97 Bn | 32.03% |
| 2 | Zoetis | 34.11 Bn | 32.16 Bn | 1.62 Bn | 28.99% |
| 3 | United Therapeutics | 23.68 Bn | 21.53 Bn | 648.10 Mn | -49.94% |
| 4 | Aurora Cannabis | 16.48 Bn | 16.40 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.19 Bn | 14.88 Bn | 800.70 Mn | -41.05% |
| 6 | Elanco Animal Health | 11.44 Bn | 11.01 Bn | 785.00 Mn | -62.71% |
| 7 | Alkermes | 7.28 Bn | 6.77 Bn | -116.06 Mn | -205.66% |
| 8 | Lantheus Holdings | 6.48 Bn | 5.98 Bn | 230.92 Mn | 36.11% |
| 9 | Hims & Hers Health | 6.35 Bn | 5.60 Bn | 396.79 Mn | -59.10% |
| 10 | Prestige Consumer Healthcare | 2.39 Bn | 2.33 Bn | 157.37 Mn | -49.21% |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -49.21% |
| Sep 30, 2025 | -69.03% |
| Jun 30, 2025 | 60.72% |
| Mar 31, 2025 | 101.64% |
| Dec 31, 2024 | 27.35% |
| Sep 30, 2024 | 28.83% |
| Jun 30, 2024 | -28.01% |
| Mar 31, 2024 | 17.56% |
| Dec 31, 2023 | -60.44% |
| Sep 30, 2023 | 29.77% |
| Jun 30, 2023 | 54.02% |
| Mar 31, 2023 | -34.02% |
| Dec 31, 2022 | 546.18% |
| Sep 30, 2022 | 134.16% |
| Jun 30, 2022 | 85.84% |
| Mar 31, 2022 | 31.65% |
| Dec 31, 2021 | -22.16% |
| Sep 30, 2021 | -258.97% |
| Jun 30, 2021 | 303.48% |
| Mar 31, 2021 | -32.17% |